A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
Status:
Not yet recruiting
Trial end date:
2024-12-25
Target enrollment:
Participant gender:
Summary
This study will look at how much weight participants will lose and how much blood sugar
control they achieve from the start to the end of the study. The weight loss in participants
taking the investigational high dose of semaglutide will be compared to the weight loss in
people taking "dummy" medicine and a lower dose of semaglutide. In addition to taking the
medicine, participants will have talks with study staff about healthy food choices and how to
be more physically active. Participants will either get semaglutide or "dummy" medicine.
Which treatment participants get is decided by chance. Participants are more likely (4 out of
5) to get semaglutide than the "dummy" medicine. The study medicine will be injected briefly,
under skin, with a thin needle, typically in the stomach, thighs, or upper arms. After
receiving first dose, the dose of semaglutide will be gradually increased until reaching the
target dose. The study will last for about 1.5 years.